Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No More Rebates: HHS Proposed Rule Revises Anti-Kickback Safe Harbor

Executive Summary

Proposed US rule would establish two new safe harbors against anti-kickback enforcement, one covering price reductions at the point of sale and the other protecting flat service fees paid by manufacturers to pharmacy benefit managers. But rebates to "PBMs to buy formulary position" in Medicare/Medicaid would lose protection.

You may also be interested in...



Medicare Part D Drug Rebate Rule Finally Sees Light Of Day: Now What?

Assurances from HHS Secretary Azar that rule will not significantly raise premiums and federal spending amount to a request to ‘just trust me.’

BIO 2020 Notebook: Conversations On Rebates, Racism And Remote Working

News and views from day four of BIO Digital also include discussion of whether the pandemic is discouraging mega mergers.

BIO 2020 Notebook: Conversations On Rebates, Racism, And Remote Working

News and views from day four of BIO Digital also include discussion of whether the pandemic is discouraging mega mergers.

Related Content

Topics

UsernamePublicRestriction

Register

PS124678

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel